Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5546188 | Current Opinion in Virology | 2017 | 8 Pages |
Abstract
Antiretroviral therapy can efficiently control HIV viral replication, resulting in low viral loads and sustained CD4+ T cell counts in HIV-infected persons. However, fast viral rebound occurs in most infected persons when therapy is interrupted. The principal component of persistent infection is a latent but replication-competent HIV reservoir. The long half-life of this reservoir is a major barrier to cure, and its elimination is the target of important research efforts. Animal models that can recapitulate this aspect of human infection are needed to examine the HIV reservoir in tissues in vivo, and to test eradication strategies. In this review, we will summarize recent studies using humanized mouse models to examine different aspects of the viral reservoir.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Maud Deruaz, Andrew M Tager,